Vida Ventures Advisors, LLC
Q1 2025 13F Holdings
- Locationboston, MA
- Num holdings
3
- Value ($000)
$13,638
- Date Filed04/03/2025
- Form type13F-HR
- CIK0001831423
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
KYTX Kyverna Therapeutics, Inc. | COMMON STOCK | 501976104 | $8.73M | 64 % | 4,523,924 | ||
ALLO Allogene Therapeutics, Inc. | COMMON STOCK | 019770106 | $2.63M | 19 % | 1,798,163 | ||
KRON Kronos Bio, Inc. | COMMON STOCK | 50107A104 | $2.28M | 17 % | 2,765,314 |
Rows Per Page
10
- 10
- 50
- 100